Inactive Instrument

PositiveID Corp Stock OTC Bulletin Board

Equities

Auto & Truck Manufacturers

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for PositiveID Corp
PositiveID Corporation Announces the Resignation of Lyle L. Probst, the President CI
PositiveID Seeks Sale Of Assets CI
PositiveID Corporation to Exhibit its Caregiver Non-Contact Thermometer at the American Association of Critical-Care Nurses Exposition CI
PositiveID Corporation will Change its Ticker to PSID from PSIDD CI
PositiveID Corporation will Change its Ticker to PSID.D from PSID CI
PositiveID Corporation Announces Earnings Results for the Quarter and Year Ended December 31, 2017 CI
PositiveID Corporation Auditor Raises 'Going Concern' Doubt CI
PositiveID to Exhibit Its Caregiver Non-Contact Thermometer At Ems, A Journal of Emergency Medical Services Conference and Exposition, February 21-23 CI
PositiveID Corporation announced that it has received $0.08 million in funding from Apollo Global Management, LLC CI
PositiveID Corporation announced that it has received $0.05 million in funding CI
PositiveID Corporation announced that it has received $0.1 million in funding CI
PositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDX CI
PositiveID Corporation announced that it has received $0.08 million in funding CI
PositiveID Corporation announced that it expects to receive $0.08 million in funding from GHS Investments, LLC CI
PositiveID Corporation Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability CI
More news
PositiveID Corporation, formerly VeriChip Corporation, is a life sciences and technology company focused on the healthcare and homeland security markets. The Company operates through three segments: Molecular Diagnostics, Medical Devices and Mobile Labs. It develops molecular diagnostic systems for medical testing and bio-threat detection. Its Microfluidic Bio-agent Autonomous Networked Detector system is an airborne bio-threat detection system developed for the homeland defense industry to detect biological weapons of mass destruction. It is developing Firefly Dx, an automated pathogen detection system for diagnostics, both for clinical and point-of-need applications. Through its contractual control of Thermomedics, Inc., it markets and sells the Caregiver product for clinical use. Its subsidiary, E-N-G Mobile Systems, Inc., operates in specialty technology vehicle market, with a focus on mobile laboratories, command and communications applications, and mobile cellular systems.
More about the company